-
公开(公告)号:EP3519420B1
公开(公告)日:2020-11-11
申请号:EP17772731.0
申请日:2017-09-28
IPC分类号: C07H21/02 , C07H19/23 , A61K31/7076 , A61P37/00
-
2.PYRIMIDINE-SUBSTITUTED PYRROLIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF 有权
标题翻译: 嘧啶取代的吡咯烷衍生物,药物组合物及其用途公开(公告)号:EP2986604B1
公开(公告)日:2017-12-20
申请号:EP14716333.1
申请日:2014-04-10
IPC分类号: C07D405/14 , C07D413/14 , C07D491/08 , C07D403/04 , C07D403/14 , C07D417/14 , C07D491/04 , C07D498/04 , A61P3/00 , A61K31/506 , A61K31/5377 , A61K31/5386
CPC分类号: C07D417/14 , C07D403/04 , C07D403/14 , C07D405/14 , C07D413/14 , C07D491/04 , C07D491/08 , C07D498/04
-
3.SUBSTITUTED HETEROARYL- AND ARYLALKYNYL BENZENE DERIVATIVES AS ACC-INHIBITORS FOR THE TREATMENT OF METABOLIC DISEASES 有权
标题翻译: 取代的杂和ARYLALKYNYLBENZOL衍生物作为抑制剂ACC治疗代谢性疾病公开(公告)号:EP2611771B1
公开(公告)日:2016-11-23
申请号:EP11752529.5
申请日:2011-09-01
发明人: ROTH, Gerald Juergen , FLECK, Martin , HEINE, Niklas , KLEY, Joerg , LEHMANN-LINTZ, Thorsten , NEUBAUER, Heike , NOSSE, Bernd
IPC分类号: C07C233/16 , C07C233/57 , C07C233/64 , C07C255/50 , C07C271/16 , C07C275/24 , C07D209/10 , C07D213/08 , C07D213/24 , C07D213/60 , C07D231/12 , C07D233/54 , C07D239/26 , C07D239/42 , C07D241/12
CPC分类号: C07C233/18 , C07B2200/07 , C07C233/05 , C07C233/13 , C07C233/20 , C07C233/31 , C07C233/36 , C07C233/47 , C07C233/58 , C07C233/60 , C07C235/08 , C07C235/40 , C07C237/08 , C07C237/22 , C07C237/42 , C07C255/19 , C07C255/46 , C07C255/60 , C07C271/16 , C07C275/24 , C07C275/40 , C07C311/04 , C07C311/10 , C07C311/14 , C07C317/44 , C07C323/41 , C07C2601/02 , C07C2601/04 , C07C2601/08 , C07C2602/08 , C07D205/04 , C07D205/08 , C07D207/10 , C07D207/12 , C07D207/325 , C07D209/08 , C07D209/44 , C07D211/16 , C07D211/76 , C07D213/30 , C07D213/40 , C07D213/64 , C07D213/643 , C07D213/65 , C07D213/74 , C07D213/75 , C07D213/79 , C07D213/82 , C07D215/12 , C07D217/06 , C07D231/12 , C07D231/14 , C07D233/64 , C07D233/90 , C07D237/08 , C07D237/14 , C07D239/26 , C07D239/28 , C07D239/34 , C07D239/38 , C07D239/42 , C07D239/52 , C07D249/10 , C07D253/07 , C07D261/08 , C07D261/14 , C07D261/18 , C07D263/32 , C07D263/34 , C07D263/58 , C07D271/08 , C07D277/24 , C07D277/28 , C07D277/56 , C07D295/088 , C07D295/192 , C07D305/06 , C07D305/08 , C07D307/14 , C07D307/24 , C07D307/68 , C07D307/79 , C07D309/12 , C07D317/62 , C07D319/08 , C07D321/10 , C07D401/04 , C07D401/08 , C07D401/12 , C07D403/04 , C07D405/12 , C07D413/12 , C07D417/12
-
4.
公开(公告)号:EP2614054B1
公开(公告)日:2014-11-19
申请号:EP11754650.7
申请日:2011-09-05
IPC分类号: C07D239/42 , C07C235/34 , C07D213/64 , A61K31/44 , A61P3/10
CPC分类号: C07D239/42 , A61K31/44 , C07C235/34 , C07C235/36 , C07C235/38 , C07C237/22 , C07C255/25 , C07D213/64
-
公开(公告)号:EP3774833A1
公开(公告)日:2021-02-17
申请号:EP19712199.9
申请日:2019-03-22
IPC分类号: C07H21/02 , A61P29/00 , A61P35/00 , A61K31/7084
-
6.NEW AZETIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF 有权
标题翻译: NEW氮杂环丁烷衍生物,其药物组合物和使用公开(公告)号:EP2797885B1
公开(公告)日:2016-08-10
申请号:EP12813885.6
申请日:2012-12-28
IPC分类号: C07D205/04 , C07D401/14 , C07D403/14 , C07D407/14 , C07D413/14 , C07D417/14 , A61K31/397 , A61P3/04 , A61P3/10
CPC分类号: C07D205/04 , C07D401/12 , C07D401/14 , C07D403/12 , C07D403/14 , C07D405/14 , C07D407/14 , C07D413/14 , C07D417/12 , C07D417/14
-
7.
公开(公告)号:EP2785690B1
公开(公告)日:2016-07-13
申请号:EP12791809.2
申请日:2012-11-30
IPC分类号: C07D211/22 , C07D211/34 , C07D401/04 , A61K31/445 , A61K31/5377 , A61K31/506 , A61P3/00
CPC分类号: C07D211/34 , C07D211/22 , C07D401/04 , C07D413/14
-
8.NEW PYRROLIDINE DERIVATIVES AND THEIR USE AS ACETYL-COA CARBOXYLASE INHIBITORS 有权
标题翻译: NEUE PYRROLIDIN- DERIVATE UND IHRE VERWENDUNG ALS ACETYL-COA CARBOXYLASE INHIBITOREN公开(公告)号:EP2903982A1
公开(公告)日:2015-08-12
申请号:EP13771485.3
申请日:2013-10-02
IPC分类号: C07D403/12 , C07D401/12 , C07D405/04 , C07D405/12 , C07D413/12 , C07D417/12 , C07D471/04 , C07D487/04 , C07D207/12 , C07D207/28 , A61K31/41 , A61P3/04 , A61P3/10
CPC分类号: C07D207/12 , C07D207/28 , C07D401/12 , C07D403/12 , C07D405/04 , C07D405/12 , C07D413/12 , C07D417/12 , C07D471/04 , C07D487/04
摘要: The invention relates to new pyrrolidine derivatives of the formula (I) to their use as medicaments, to methods for their therapeutic use and to pharmaceutical compositions containing them.
摘要翻译: 吡咯烷衍生物及其用作治疗肥胖和2型糖尿病的药物。
-
9.
公开(公告)号:EP3774834A1
公开(公告)日:2021-02-17
申请号:EP19713011.5
申请日:2019-03-22
IPC分类号: C07H21/02 , C07H21/04 , C07H19/213 , A61P29/00 , A61P35/00 , A61K31/7084
-
公开(公告)号:EP3519420A1
公开(公告)日:2019-08-07
申请号:EP17772731.0
申请日:2017-09-28
IPC分类号: C07H21/02 , C07H19/23 , A61K31/7076 , A61P37/00
摘要: wherein the groups R1, R2 and R3 are defined as in claim 1, which have valuable pharmacological properties, particularly are modulators of STING.
-
-
-
-
-
-
-
-
-